Highlights
A collection of news and information related to Myriad Genetics Incorporated published by this site and its partners.
Displaying items 1-12 of 12
» View all items
-
Angelina Jolie's courageous act will save women's lives
Four days after her April 27 breast reconstruction, the third and final surgery aimed at sparing her an early death from breast cancer, Angelina Jolie was in good spirits at home. Upon paying a house call, her surgeon, Dr. Kristi Funk of the Pink...
Tags: Patents, Copyrights and Trademarks, Medical Specialization, Breast Cancer, Ovarian Cancer, Science and Technology
-
Angelina Jolie mastectomy: A closer look at DNA, breast cancer risk
By opting for surgery to remove her breasts while they were still healthy, Angelina Jolie joined a growing number of women who have used genetic testing to take control of their health. Here are answers to some common questions about how DNA...
Tags: American Cancer Society, Diseases and Illnesses, Breast Cancer, Ovarian Cancer, Healthcare Provider
-
Angelina Jolie and the fate of breast cancer genes
Angelina Jolie’s Op-Ed in the New York Times about getting a double mastectomy after learning that she was at risk of getting breast cancer struck a chord with fellow celebs as well as with Los Angeles Times staffers Anna Gorman and Paul Whitefield,...
Tags: Anna Gorman, Patents, Copyrights and Trademarks, Medical Specialization, Breast Cancer, Diseases and Illnesses
-
Can a company patent your DNA? Supreme Court hears BRCA gene case
Can a private company own rights to your DNA? The nine justices of the Supreme Court will consider that question Monday as lawyers for Myriad Genetics make their best case that the company should be able to keep its patent on two genes known to...
Tags: Patents, Copyrights and Trademarks, Medical Specialization, Breast Cancer, Ovarian Cancer, Science and Technology
-
Supreme Court critical of patents on human genes
WASHINGTON — The Supreme Court justices said Monday they were highly skeptical of the idea that a company or a scientist can hold a patent on human genes and prevent others from testing or using them. “What about the first person who found a...
Tags: Patents, Copyrights and Trademarks, Medical Specialization, Breast Cancer, Car Guides and Reviews, John G. Roberts, Jr.
-
Supreme Court seems opposed to granting patents on human genes
WASHINGTON — The Supreme Court took up a deceptively simple question in a case brought by breast cancer patients and medical researchers: Are human genes patentable? The answer appeared to be "no" during Monday's oral arguments. The justices...
Tags: Patents, Copyrights and Trademarks, Eryn Brown, John G. Roberts, Jr., Science and Technology, Justice System
-
Supreme Court to consider validity of patents on genes
WASHINGTON -- The Supreme Court will hear an appeal Monday from breast cancer patients and medical researchers who say the U.S. Patent and Trademark Office made a mistake when it granted a Utah company an exclusive right to profit from testing genes...
Tags: Patents, Copyrights and Trademarks, Medical Specialization, Breast Cancer, Car Guides and Reviews, Science and Technology
-
Supreme Court considers gene patents; scientists react
As the U.S. Supreme Court heard oral arguments in the case against Myriad Genetics, scientists who are skeptical of the idea of patenting genes said they were hopeful that the justices would overturn the Utah company's claims. "I was on pins and needles...
Tags: Patents, Copyrights and Trademarks, Medical Specialization, Ovarian Cancer, Science and Technology, Ronald Reagan UCLA Medical Center
-
Why genetic patents are good for patients [Blowback]
In their April 12 Op-Ed article "Who should own DNA? All of us," Marcy Darnovsky and Karuna Jaggar write about Myriad's patents on BRCA1 and BRCA2, the so-called breast cancer genes (which were under review Monday at the U.S. Supreme Court), as if they...
Tags: Patents, Copyrights and Trademarks, Chemical Industry, U.S. Supreme Court, Breast Cancer, Medical Research
-
The Supreme Court looks at gene patents, worries about biotech
When the Supreme Court took up the question Monday of whether genes could be patented, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes...
Tags: Patents, Copyrights and Trademarks, Ovarian Cancer, John G. Roberts, Jr., Entertainment Events, Nobel Prize Awards
-
Who should own DNA? All of us
Most court cases involving patent law are corporate battles, with one company suing another for infringing on its intellectual property rights and, therefore, profits. Big companies fighting over big money can seem painfully irrelevant, especially when so...
Tags: Patents, Copyrights and Trademarks, Diseases and Illnesses, Ovarian Cancer, Science and Technology, Chemical Industry
-
Genes are complex; gene patents might be more so
Booster ShotsGenetic research breakthroughs have come to be expected -- greeted with a sense of inevitability and the quiet assurance that science will ultimately puzzle out, then cure, human disease. But how those breakthroughs actually yield benefits is complicated....
May 21, 2013
|Column| Los Angeles Times
May 14, 2013
|Story| Los Angeles Times
May 14, 2013
|Story| Los Angeles Times
Apr 15, 2013
|Story| Los Angeles Times
Apr 15, 2013
|Story| Los Angeles Times
Apr 16, 2013
|Story| Los Angeles Times
Apr 15, 2013
|Story| Los Angeles Times
Apr 15, 2013
|Story| Los Angeles Times
Apr 15, 2013
|Story| Los Angeles Times
Apr 15, 2013
|Story| Los Angeles Times
Apr 12, 2013
|Story| Los Angeles Times
Jan 11, 2010
| Los Angeles Times
Original site for Myriad Genetics Incorporated topic gallery.
